The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| JOUNCE THERAPEUTICS, INC. | COM | 481116101 | 21,342 | 3,048,780 | SH | DFND | 1,2,3 | 3,048,780 | 0 | 0 | |
| PLIANT THERAPEUTICS, INC. | COM | 729139105 | 132,666 | 5,839,160 | SH | DFND | 1,2,3 | 5,839,160 | 0 | 0 | |
| VOYAGER THERAPEUTICS, INC. | COM | 92915B106 | 45,697 | 6,391,176 | SH | DFND | 1,2,3 | 6,391,176 | 0 | 0 | |
| FULCRUM THERAPEUTICS, INC. | COM | 359616109 | 69,817 | 5,962,202 | SH | DFND | 1,2,3 | 5,962,202 | 0 | 0 | |
| REVOLUTION MEDICINES, INC. | COM | 76155X100 | 278,081 | 7,024,031 | SH | DFND | 1,2,3 | 7,024,031 | 0 | 0 | |
| NURIX THERAPEUTICS, INC. | COM | 67080M103 | 178,293 | 5,422,549 | SH | DFND | 1,2,3 | 5,422,549 | 0 | 0 | |
| RELAY THERAPEUTICS, INC. | COM | 75943R102 | 438,504 | 10,551,115 | SH | DFND | 1,2,3 | 10,551,115 | 0 | 0 | |